Tech Company Financing Transactions
BioStable Funding Round
BioStable, operating out of Austin, received $625 thousand from TriStar Technology Fund.
Transaction Overview
Company Name
Announced On
12/31/2012
Transaction Type
Venture Equity
Amount
$625,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2621 Ridgepoint Dr. 100
Austin, TX 78754
USA
Austin, TX 78754
USA
Phone
Website
Email Address
Overview
BioStable develops innovative new products for the treatment of cardiovascular diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
John Wheeler
VP - Bus. Development
Thomas Williamson
VP - Operations
Julie Thomas
Browse more venture capital transactions:
Prev: 12/31/2012: Vendscreen venture capital transaction
Next: 12/31/2012: Crimson Hexagon venture capital transaction
Share this article
Where The Data Comes From
We report on funding rounds that are announced publicly. VC transactions on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs